Molecular Templates, Inc.
MTEM
MTEM was delisted on the 24th of December, 2024.
87 hedge funds and large institutions have $313M invested in Molecular Templates, Inc. in 2019 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 32 increasing their positions, 14 reducing their positions, and 11 closing their positions.
300% more funds holding in top 10
Funds holding in top 10: 1 → 4 (+3)
230% more capital invested
Capital invested by funds: $94.9M → $313M (+$218M)
191% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 11
129% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 14
30% more funds holding
Funds holding: 67 → 87 (+20)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$12.4M |
| 2 |
PC
Polar Capital
London,
United Kingdom
|
+$11.5M |
| 3 |
BlackRock
New York
|
+$8.57M |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$7.91M |
| 5 |
PA
Perceptive Advisors
New York
|
+$4.79M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Axa
Paris,
France
|
-$3.85M |
| 2 |
JP Morgan Chase
New York
|
-$1.11M |
| 3 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$975K |
| 4 |
Renaissance Technologies
New York
|
-$619K |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
-$595K |
MTEM Hedge Fund Activity: Q4 2019 in Review
87 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Molecular Templates, Inc. (MTEM) for Q4 2019, worth a combined $313M — up 230% from $94.9M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new MTEM positions and 11 closed out — a net gain of 21 holders — while 32 added to existing stakes and 14 trimmed.
The largest buyer was Bellevue Group, opening a new position worth an estimated $12.4M. The largest seller was Axa, cutting an estimated $3.85M.
- 87 institutional investors held Molecular Templates, Inc. (MTEM) as of Q4 2019, up from 67 in Q3 2019.
- Funds reported $313M of Molecular Templates, Inc. stock for Q4 2019, up 230% quarter-over-quarter.
- 32 funds opened new Molecular Templates, Inc. positions in Q4 2019 and 11 closed out, a net change of +21 holders.
- The largest Molecular Templates, Inc. buyer in Q4 2019 was Bellevue Group, an estimated $12.4M added.
- The largest Molecular Templates, Inc. seller in Q4 2019 was Axa, an estimated $3.85M sold.
Based on aggregated 13F filings for Q4 2019.